Typicality: | 0.635 |
Saliency: | 0.606 |
for 30 days | 16 | temporal |
in a study | 13 | location |
for 12 weeks | 11 | temporal |
subject → take → placebo | 94 |
subject → be given → placebo | 92 |
subject → be treated with → placebo | 91 |
subject → take → the placebo | 20 |
subject → get → placebo | 12 |
subject → use → placebo | 5 |
subject → have → placebo | 3 |
negative | neutral | positive |
0.174 | 0.676 | 0.150 |
Raw frequency | 317 |
Normalized frequency | 0.606 |
Modifier score | 0.889 |
Perplexity | 409.676 |